National Foundation for Infectious Diseases Announces the 2026-2027 Board of Directors

NFID Announces New Leadership for 2026-2027

The National Foundation for Infectious Diseases (NFID) has recently announced its newly appointed Board of Directors for the 2026-2027 term, highlighting a dedicated leadership team committed to advancing public health initiatives related to infectious diseases. With a robust experience within healthcare and public health sectors, the new board members aim to enhance public engagement and education about infectious diseases.

Introducing the New Board Members

Heading the new board is Dr. Monica M. Farley, who officially assumed the presidency on July 1, 2026. Dr. Farley is renowned for her expertise in infectious diseases, particularly invasive bacterial infections and vaccine-preventable diseases. Her presidency follows a successful tenure as president-elect and positions her to lead NFID as it tackles current public health challenges. Dr. Farley expressed her enthusiasm, emphasizing the important role of collaboration in overcoming today’s public health crises.

Dr. Kevin A. Ault will serve as president-elect. A prominent figure in maternal immunization and vaccine policy, Dr. Ault has previously participated as a member of the Advisory Committee on Immunization Practices (ACIP), providing valuable insights for the CDC. His experience brings a unique perspective to the board, particularly regarding vaccine initiatives and healthcare policy.

Another key appointment is Dr. Ruth Lynfield who takes on the role of vice president. With a strong background in pediatric infectious diseases and public health, Dr. Lynfield's research on emerging diseases and outbreak control aligns perfectly with NFID's mission to educate and inform.

The organization also acknowledges Dr. Jeffery A. Goad as immediate past president, whose leadership has significantly enhanced public confidence in vaccines. Kevin M. Rooney continues as the secretary-treasurer, providing vital financial oversight.

New Additions to the NFID Board of Directors

The 2026-2027 board will also welcome three new members who bring essential expertise and commitment to the foundation's goal of combating infectious diseases through education and policy advocacy. Dr. William P. Hausdorff, who has extensive experience in vaccine development, joins the board with a solid history of expanding access to vaccines globally.

Legal expert Veronica V. McNally, JD, brings her advocacy for vaccine education and public health initiatives to the board. Her leadership has been pivotal in campaigns that empower parents to make informed vaccination decisions.

Lastly, Dr. Jessica Steier, a public health scientist and science communicator, enhances the board's ability to address communication challenges in public health, especially in the context of misinformation.

A Commitment to Public Health Education

As NFID enters a new leadership phase, the foundation’s objectives remain clear: to educate and engage healthcare providers and the public on infectious diseases. The board's diverse backgrounds fuel a comprehensive approach to public health challenges focusing on scientific integrity in policy-making.

Rebecca Alvania, NFID’s chief executive officer, expressed her confidence in the new directors, stating their leadership will be crucial as the healthcare landscape continues to evolve. The board aims to strengthen partnerships across various sectors, furthering the foundation's mission of improving public health and infectious disease awareness.

In conclusion, the 2026-2027 NFID Board of Directors, led by experts devoted to infectious disease prevention and education, promises a proactive approach to tackling current and future public health challenges. As they embark on their new term, their commitment to scientific dialogue and community engagement will undoubtedly play a pivotal role in safeguarding public health amidst growing complexities in the health sector.